No takes yet. Share an insight, caveat, or question.
Randomized trial explores bivalirudin infusion for improved anticoagulation in ECMO, suggesting better circuit performance.
Wieruszewski et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: